Saturday 17 October 2026 Export CSTL’s income statement to Excel — free account

Castle Biosciences, Inc.

Castle Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $344.2 million, up 3.66% from fiscal 2024. In the quarter to June 2026, revenue grew 20.1%, EPS fell 143.8%, free cash flow fell 43.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.

31.96 1.84 −5.44%

Follow CSTL

Alert me

Market cap: $1.0B
P/E: 0.0×
Fwd P/E: −15.2×
Dividend yield: —
F-score: 3/9
Altman Z: 6.70
Beneish M: −3.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	2.03	2.16	3.28	1.93
P/FCF ratio Full definition →	0.00	160.88	39.74	26.04
P/Operating CF Full definition →	47.70	(33.16)	41.87	29.25
P/B ratio Full definition →	1.54	1.59	2.39	1.42
Price to Tangible BV Full definition →	1.93	2.02	3.04	1.81
EV/Sales Full definition →	1.31	1.42	2.44	1.13
EV/EBITDA Full definition →	0.00	0.00	0.00	142.99
EV/Operating CF Full definition →	10.99	10.00	13.03	6.26
EV/FCF Full definition →	(1,036.62)	105.78	29.55	15.21
Quick Ratio Full definition →	5.58	6.23	4.99	6.09
Current Ratio Full definition →	6.04	6.75	5.26	6.47
Net Debt/EBITDA Full definition →	(421.82)	16.83	381.44	71.19
Debt/Assets Full definition →	1.84%	1.89%	1.79%	1.85%
Debt/Equity Full definition →	0.02	0.02	0.02	0.02
Asset Turnover Full definition →	0.65	0.65	0.62	0.64
Operating CF/Net income Full definition →	(7.38)	1.52	(11.55)	(45.17)
Capex/Depreciation Full definition →	(2.35)	(3.58)	(2.34)	(5.09)
Interest Coverage Full definition →	(15.91)	(137.37)	(159.46)	(283.50)
Research and Development Expense of Revenue Full definition →	14.04%	17.24%	15.53%	15.61%
Selling, General and Administrative Expense of Revenue Full definition →	63.86%	77.56%	65.20%	67.32%
Intangible Assets out of Total Assets Full definition →	0.17	0.18	0.17	0.18
Share Based Compensation of Revenue Full definition →	11.19%	11.68%	13.11%	14.57%
Graham Net Nets Full definition →	0.34	0.33	0.22	0.40
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(2.77%)	(1.75%)	(2.16%)	(1.84%)
Free Cash Flow Yield Full definition →	(0.06%)	0.62%	2.52%	3.84%
Revenue per Share Full definition →	3.41	2.80	3.00	2.86
Operating CF per Share Full definition →	0.50	(0.74)	0.93	0.78
Capex per Share Full definition →	(0.28)	(0.42)	(0.25)	(0.51)
Free Cash Flow per Share Full definition →	0.22	(1.16)	0.68	0.27
Cash per Share Full definition →	8.78	8.76	10.33	9.89
Shareholders Equity per Share Full definition →	15.46	15.44	16.24	16.06
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	15.46	15.44	16.24	16.06
Free Cash Flow Full definition →	6.56	(34.58)	19.75	7.82
Working Capital Full definition →	284.59	280.14	292.42	302.26
Capital Expenditures Full definition →	(8.64)	(12.45)	(7.18)	(14.81)
Net Current Asset Value Full definition →	249.95	242.51	253.41	261.83
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.08	0.15	0.08	0.18
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	50.33	49.31	47.30	49.87
Average Payables Full definition →	11.42	11.77	12.81	9.51
Average Inventory Full definition →	9.47	8.66	9.19	7.61
Average Assets Full definition →	552.95	524.76	554.90	538.68
Average Common Equity Full definition →	462.70	450.86	463.35	454.05

Fold the line items

Columns are period end dates

Stockrow Weekly